These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1414627)

  • 1. PET studies on the integrity of the pre and postsynaptic dopaminergic system in Tourette syndrome.
    Brooks DJ; Turjanski N; Sawle GV; Playford ED; Lees AJ
    Adv Neurol; 1992; 58():227-31. PubMed ID: 1414627
    [No Abstract]   [Full Text] [Related]  

  • 2. Positron emission tomography evaluation of dopamine D-2 receptors in adults with Tourette syndrome.
    Singer HS; Wong DF; Brown JE; Brandt J; Krafft L; Shaya E; Dannals RF; Wagner HN
    Adv Neurol; 1992; 58():233-9. PubMed ID: 1414628
    [No Abstract]   [Full Text] [Related]  

  • 3. Bithalamical deep brain stimulation in tourette syndrome is associated with reduction in dopaminergic transmission.
    Vernaleken I; Kuhn J; Lenartz D; Raptis M; Huff W; Janouschek H; Neuner I; Schaefer WM; Gründer G; Sturm V
    Biol Psychiatry; 2009 Nov; 66(10):e15-7. PubMed ID: 19709645
    [No Abstract]   [Full Text] [Related]  

  • 4. Structural and functional studies of Gilles de la Tourette syndrome.
    Chase TN; Geoffrey V; Gillespie M; Burrows GH
    Rev Neurol (Paris); 1986; 142(11):851-5. PubMed ID: 2881340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional neuroanatomy of Tourette syndrome. Limbic-motor interactions studied with FDG PET.
    Stoetter B; Braun AR; Randolph C; Gernert J; Carson RE; Herscovitch P; Chase TN
    Adv Neurol; 1992; 58():213-26. PubMed ID: 1414626
    [No Abstract]   [Full Text] [Related]  

  • 6. Functional imaging of dopaminergic neurotransmission in Tourette syndrome.
    Segura B; Strafella AP
    Int Rev Neurobiol; 2013; 112():73-93. PubMed ID: 24295618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroimaging studies of Tourette syndrome: a decade of progress.
    Peterson BS
    Adv Neurol; 2001; 85():179-96. PubMed ID: 11530427
    [No Abstract]   [Full Text] [Related]  

  • 8. Dopaminergic Disturbances in Tourette Syndrome: An Integrative Account.
    Maia TV; Conceição VA
    Biol Psychiatry; 2018 Sep; 84(5):332-344. PubMed ID: 29656800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography and central neurotransmitter systems in movement disorders.
    Weeks RA; Brooks DJ
    Fundam Clin Pharmacol; 1994; 8(6):503-17. PubMed ID: 7721227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo evidence of deep brain stimulation-induced dopaminergic modulation in Tourette's syndrome.
    Kuhn J; Janouschek H; Raptis M; Rex S; Lenartz D; Neuner I; Mottaghy FM; Schneider F; Schaefer WM; Sturm V; Gründer G; Vernaleken I
    Biol Psychiatry; 2012 Mar; 71(5):e11-3. PubMed ID: 22129758
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuromodulation in Tourette syndrome: dopamine and beyond.
    Buse J; Schoenefeld K; Münchau A; Roessner V
    Neurosci Biobehav Rev; 2013 Jul; 37(6):1069-84. PubMed ID: 23085211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurobiology of basal ganglia and Tourette syndrome: striatal and dopamine function.
    Albin RL
    Adv Neurol; 2006; 99():99-106. PubMed ID: 16536355
    [No Abstract]   [Full Text] [Related]  

  • 13. Dopamine receptor availability in Tourette's syndrome.
    George MS; Robertson MM; Costa DC; Ell PJ; Trimble MR; Pilowsky L; Verhoeff NP
    Psychiatry Res; 1994 Dec; 55(4):193-203. PubMed ID: 7701034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine and myopia.
    Khamar BM; Enoch JM; Lakshminarayanan V; Chader GJ
    Optom Vis Sci; 1990 Dec; 67(12):908-10. PubMed ID: 2082239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPECT imaging of cerebral blood flow in Tourette syndrome.
    Riddle MA; Rasmusson AM; Woods SW; Hoffer PB
    Adv Neurol; 1992; 58():207-11. PubMed ID: 1414625
    [No Abstract]   [Full Text] [Related]  

  • 16. Tourette's syndrome and the opioid system.
    Weeks RA; Lees AJ; Brooks DJ
    Lancet; 1994 Apr; 343(8905):1107-8. PubMed ID: 7909135
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuroleptic effects in Tourette syndrome predict dopamine excess and acetylcholine deficiency.
    Stahl SM; Berger PA
    Biol Psychiatry; 1982 Sep; 17(9):1047-53. PubMed ID: 6128037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette's syndrome.
    Singer HS; Hahn IH; Moran TH
    Ann Neurol; 1991 Oct; 30(4):558-62. PubMed ID: 1838678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biogenic amine metabolism in Tourette syndrome.
    Butler IJ; Koslow SH; Seifert WE; Caprioli RM; Singer HS
    Ann Neurol; 1979 Jul; 6(1):37-9. PubMed ID: 292354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tourette syndrome in progressive dementia].
    Oelenberg W; Pach J
    Fortschr Neurol Psychiatr; 1993 Feb; 61(2):35-7. PubMed ID: 8449475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.